Inhibition of aryl hydrocarbon receptor signaling and induction of NRF2-mediated antioxidant activity by cinnamaldehyde in human keratinocytes

Journal of Dermatological Science

Volumn 85, Issue 1, 2017, Pages 36-43

  Uchi, Hiroshi ^a   Yasumatsu, Mao ^b   Morino Koga, Saori ^a   Mitoma, Chikage ^b   Furue, Masutaka ^a,b  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Aryl hydrocarbon receptor; Cinnamaldehyde; Keishibukuryogan; Keratinocytes; Nrf2

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CINNAMALDEHYDE; CINNAMOMUM CASSIA EXTRACT; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HO1; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; ACROLEIN; AHR PROTEIN, HUMAN; ANTIOXIDANT; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; BENZO[A]PYRENE; DIOXIN; HEME OXYGENASE 1; HMOX1 PROTEIN, HUMAN; NFE2L2 PROTEIN, HUMAN; PLANT EXTRACT; POLLUTANT; REACTIVE OXYGEN METABOLITE;

ANALYSIS OF VARIANCE; ANTIBODY LABELING; ANTIGEN SPECIFICITY; ANTIOXIDANT ACTIVITY; ARTICLE; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DIMERIZATION; ENVIRONMENTAL STRESS; ENZYME INHIBITION; FLUORESCENCE MICROSCOPY; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOFLUORESCENCE LOCALIZATION; KERATINOCYTE; LIGAND BINDING; NONHUMAN; OXIDATIVE STRESS; PHYTOCHEMISTRY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; CELL LINE; CHEMISTRY; CHINESE MEDICINE; CINNAMOMUM CASSIA; CYTOLOGY; DRUG EFFECTS; EPIDERMIS; GENETICS; HUMAN; METABOLISM; OXIDATION REDUCTION REACTION; POLLUTANT; RNA INTERFERENCE; TOXICITY;

ACROLEIN; ANTIOXIDANTS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BENZO(A)PYRENE; CELL LINE; CINNAMOMUM AROMATICUM; DIOXINS; ENVIRONMENTAL POLLUTANTS; EPIDERMIS; HEME OXYGENASE-1; HUMANS; KERATINOCYTES; MEDICINE, KAMPO; NF-E2-RELATED FACTOR 2; OXIDATION-REDUCTION; OXIDATIVE STRESS; PLANT EXTRACTS; REACTIVE OXYGEN SPECIES; RECEPTORS, ARYL HYDROCARBON; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 84991786853     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2016.10.003     Document Type: Article

References (30)

1. [1] Esser, C., Rannug, A., Stockinger, B., The aryl hydrocarbon receptor in immunity. Trends Immunol. 30 (2009), 447–454.
2. [2] Stockinger, B., Hirota, K., Duarte, J., Veldhoen, M., External influences on the immune system via activation of the aryl hydrocarbon receptor. Semin. Immunol. 23 (2011), 99–105.
3. [3] Matsumoto, S., Akahane, M., Kanagawa, Y., Kajiwara, J., Mitoma, C., Uchi, H., et al. Unexpectedly long half-lives of blood 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) levels in Yusho patients. Environ. Health, 14, 2015, 76.
4. [4] Mitoma, C., Uchi, H., Tsukimori, K., Yamada, H., Akahane, M., Imamura, T., et al. Yusho and its latest findings-a review in studies conducted by the Yusho Group. Environ. Int. 82 (2015), 41–48.
5. [5] Guo, Y.L., Lambert, G.H., Hsu, C.C., Hsu, M.M., Yucheng: health effects of prenatal exposure to polychlorinated biphenyls and dibenzofurans. Int. Arch. Occup. Environ. Health 77 (2004), 153–158.
6. [6] Warner, M., Mocarelli, P., Brambilla, P., Wesselink, A., Samuels, S., Signorini, S., et al. Diabetes, metabolic syndrome, and obesity in relation to serum dioxin concentrations: the Seveso women's health study. Environ. Health Perspect. 121 (2013), 906–911.
7. [7] Fernandez-Salguero, P.M., Hilbert, D.M., Rudikoff, S., Ward, J.M., Gonzalez, F.J., Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicol Appl. Pharmacol. 140 (1996), 173–179.
8. [8] Shimizu, Y., Nakatsuru, Y., Ichinose, M., Takahashi, Y., Kume, H., Mimura, J., et al. Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. Proc. Natl. Acad. Sci. U. S. A. 97 (2000), 779–782.
9. [9] Furue, M., Takahara, M., Nakahara, T., Uchi, H., Role of AhR/ARNT system in skin homeostasis. Arch. Dermatol. Res. 306 (2014), 769–779.
10. [10] Barygina, V., Becatti, M., Lotti, T., Moretti, S., Taddei, N., Fiorillo, C., Treatment with low-dose cytokines reduces oxidative-mediated injury in perilesional keratinocytes from vitiligo skin. J. Dermatol. Sci. 79 (2015), 163–170.
11. [11] Basak, P.Y., Gultekin, F., Kilinc, I., The role of the antioxidative defense system in papulopustular acne. J. Dermatol. 28 (2001), 123–127.
12. [12] Furue, M., Tsuji, G., Mitoma, C., Nakahara, T., Chiba, T., Morino-Koga, S., et al. Gene regulation of filaggrin and other skin barrier proteins via aryl hydrocarbon receptor. J. Dermatol. Sci. 80 (2015), 83–88.
13. [13] Takei, K., Mitoma, C., Hashimoto-Hachiya, A., Uchi, H., Takahara, M., Tsuji, G., et al. Antioxidant soybean tar Glyteer rescues T-helper-mediated downregulation of filaggrin expression via aryl hydrocarbon receptor. J. Dermatol. 42 (2015), 171–180.
14. [14] Wu, Z., Uchi, H., Morino-Koga, S., Nakamura-Satomura, A., Kita, K., Shi, W., et al. Z-ligustilide inhibits benzo(a)pyrene-induced CYP1A1 upregulation in cultured human keratinocytes via ROS-dependent Nrf2 activation. Exp. Dermatol. 23 (2014), 260–265.
15. [15] Takei, K., Hashimoto-Hachiya, A., Takahara, M., Tsuji, G., Nakahara, T., Furue, M., Cynaropicrin attenuates UVB-induced oxidative stress via the AhR-Nrf2-Nqo1 pathway. Toxicol. Lett. 234 (2015), 74–80.
16. [16] Maher, J., Yamamoto, M., The rise of antioxidant signaling-the evolution and hormetic actions of Nrf2. Toxicol. Appl. Pharmacol. 244 (2010), 4–15.
17. [17] Nakahara, T., Mitoma, C., Hashimoto-Hachiya, A., Takahara, M., Tsuji, G., Uchi, H., et al. Antioxidant opuntia ficus-indica extract activates AHR-NRF2 signaling and upregulates filaggrin and loricrin expression in human keratinocytes. J. Med. Food 18 (2015), 1143–1149.
18. [18] Singletary, K.W., Cinnamon: overview of health benefits. Nutr. Today 43 (2008), 263–266.
19. [19] Muhammad, J.S., Zaidi, S.F., Shaharyar, S., Refaat, A., Usmanghani, K., Saiki, I., et al. Anti-inflammatory effect of cinnamaldehyde in Helicobacter pylori induced gastric inflammation. Biol. Pharm. Bull. 38 (2015), 109–115.
20. [20] Zhao, J., Zhang, X., Dong, L., Wen, Y., Zheng, X., Zhang, C., et al. Cinnamaldehyde inhibits inflammation and brain damage in a mouse model of permanent cerebral ischemia. Br. J. Pharmacol. 172 (2015), 5009–5023.
21. [21] Tsuji, G., Takahara, M., Uchi, H., Takeuchi, S., Mitoma, C., Moroi, Y., et al. An environmental contaminant benzo(a)pyrene, induces oxidative stress-mediated interleukin-8 production in human keratinocytes via the aryl hydrocarbon receptor signaling pathway. J. Dermatol. Sci. 62 (2011), 42–49.
22. [22] Nakamura, M., Ueda, Y., Hayashi, M., Kato, H., Furuhashi, T., Morita, A., Tobacco smoke-induced skin pigmentation is mediated by the aryl hydrocarbon receptor. Exp. Dermatol. 22 (2013), 556–558.
23. [23] Mohammadi-Bardbori, A., Bengtsson, J., Rannug, U., Rannug, A., Wincent, E., Quercetin resveratrol, and curcumin are indirect activators of the aryl hydrocarbon receptor (AHR). Chem. Res. Toxicol. 25 (2012), 1878–1884.
24. [24] Tsuji, G., Takahara, M., Uchi, H., Matsuda, T., Chiba, T., Takeuchi, S., et al. Identification of ketoconazole as an AhR-Nrf2 activator in cultured human keratinocytes: the basis of its anti-inflammatory effect. J. Invest. Dermatol. 132 (2012), 59–68.
25. [25] Ishida, T., Takeda, T., Koga, T., Yahata, M., Ike, A., Kuramoto, C., et al. Attenuation of 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity by resveratrol: a comparative study with different routes of administration. Biol. Pharm. Bull. 32 (2009), 876–881.
26. [26] Wu, Z., Uchi, H., Morino-Koga, S., Shi, W., Furue, M., Z-ligustilide ameliorated ultraviolet B-induced oxidative stress and inflammatory cytokine production in human keratinocytes through upregulation of Nrf2/HO-1 and suppression of NF-κB pathway. Exp. Dermatol. 24 (2015), 703–708.
27. [27] Ezzedine, K., Eleftheriadou, V., Whitton, M., van Geel, N., Vitiligo. Lancet 386 (2015), 74–84.
28. [28] Maegawa, H., Nakamura, T., Saito, K., Regulation of traditional herbal medicinal products in Japan. J. Ethnopharmacol. 158:Pt. B (2014), 511–515.
29. [29] Terauchi, M., Akiyoshi, M., Owa, Y., Kato, K., Obayashi, S., Kubota, T., Effects of the Kampo medication keishibukuryogan on blood pressure in perimenopausal and postmenopausal women. Int. J. Gynaecol. Obstet. 114 (2011), 149–152.
30. [30] Hayashi, S., Shibutani, S., Okubo, H., Shimogawara, T., Ichinose, T., Ito, Y., et al. Examination of clinical efficacy of keishibukuryogan on non-specific complaints associated with varicose veins of the lower extremity. Ann. Vasc. Dis. 7 (2014), 266–273.